101 related articles for article (PubMed ID: 20090458)
1. Increased bone marrow activity on F-18-FDG PET/CT in granulocyte colony stimulating factor producing anaplastic thyroid carcinoma.
Zweifel M; Stenner-Liewen F; Weber A; Samaras P; Zaugg K; Knuth A; Soyka JD
Clin Nucl Med; 2010 Feb; 35(2):103-4. PubMed ID: 20090458
[No Abstract] [Full Text] [Related]
2. (18)F-FDG-PET/CT findings of granulocyte colony stimulating factor (G-CSF)-producing lung tumors.
Morooka M; Kubota K; Murata Y; Shibuya H; Ito K; Mochizuki M; Akashi T; Chiba T; Nomura T; Ito H; Morita T
Ann Nucl Med; 2008 Aug; 22(7):635-9. PubMed ID: 18756367
[TBL] [Abstract][Full Text] [Related]
3. Inhomogeneous bone marrow uptake caused by G-CSF mimics multiple bone metastases on FDG-PET.
Nakamoto Y; Suga T; Hara T; Ishizu K; Togashi K
Clin Nucl Med; 2010 Feb; 35(2):74-6. PubMed ID: 20090448
[TBL] [Abstract][Full Text] [Related]
4. Correlations between 18F-FDG uptake by bone marrow and hematological parameters: measurements by PET/CT.
Murata Y; Kubota K; Yukihiro M; Ito K; Watanabe H; Shibuya H
Nucl Med Biol; 2006 Nov; 33(8):999-1004. PubMed ID: 17127173
[TBL] [Abstract][Full Text] [Related]
5. F-18 FDG PET imaging in a patient with granulocyte colony stimulating factor producing pulmonary pleomorphic carcinoma.
Takahashi S; Kuwabara K; Sawafuji M; Akiduki S; Ishizaka A
Clin Nucl Med; 2008 Aug; 33(8):555-7. PubMed ID: 18645378
[No Abstract] [Full Text] [Related]
6. Interesting image. Unsuspected synchronous thyroid carcinoma revealed on a post-therapy F-18 FDG PET/CT, in a patient with follicular lymphoma.
Makis W; Hickeson M; Novales-Diaz JA
Clin Nucl Med; 2010 Nov; 35(11):879-81. PubMed ID: 20940548
[No Abstract] [Full Text] [Related]
7. Renal cell carcinoma presenting as isolated thyroid metastasis 13 years after radical nephrectomy, detected on F-18 FDG PET/CT.
Manohar K; Mittal BR; Kashyap R; Bhattacharya A; Singh B
Clin Nucl Med; 2010 Oct; 35(10):818-9. PubMed ID: 20838298
[TBL] [Abstract][Full Text] [Related]
8. F-18 FDG PET/CT demonstration of an adrenal metastasis in a patient with anaplastic thyroid cancer.
Iagaru A; McDougall IR
Clin Nucl Med; 2007 Jan; 32(1):13-5. PubMed ID: 17179796
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of metabolic tumor volume assessed by 18F-FDG PET/CT added to SUVmax for characterization of thyroid 18F-FDG incidentaloma.
Kim BH; Kim SJ; Kim H; Jeon YK; Kim SS; Kim IJ; Kim YK
Nucl Med Commun; 2013 Sep; 34(9):868-76. PubMed ID: 23797273
[TBL] [Abstract][Full Text] [Related]
10. Role of [(18)F]FDG-PET/CT in the detection of occult recurrent medullary thyroid cancer.
Skoura E; Rondogianni P; Alevizaki M; Tzanela M; Tsagarakis S; Piaditis G; Tolis G; Datseris IE
Nucl Med Commun; 2010 Jun; 31(6):567-75. PubMed ID: 20335822
[TBL] [Abstract][Full Text] [Related]
11. Interaction of colony-stimulating factors and fluorodeoxyglucose f(18) positron emission tomography.
Mayer D; Bednarczyk EM
Ann Pharmacother; 2002 Nov; 36(11):1796-9. PubMed ID: 12398579
[TBL] [Abstract][Full Text] [Related]
12. Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer.
Finkelstein SE; Grigsby PW; Siegel BA; Dehdashti F; Moley JF; Hall BL
Ann Surg Oncol; 2008 Jan; 15(1):286-92. PubMed ID: 17882493
[TBL] [Abstract][Full Text] [Related]
13. [A case of lung cancer producing granulocyte colony-stimulating factor with a significantly high uptake in the bones observed by a FDG-PET scan].
Hidaka D; Koshizuka H; Hiyama J; Nakatsubo S; Ikeda K; Hayashi A; Fujii A; Sawamoto R; Misumi Y; Miyagawa Y
Nihon Kokyuki Gakkai Zasshi; 2009 Mar; 47(3):259-63. PubMed ID: 19348277
[TBL] [Abstract][Full Text] [Related]
14. F-18 FDG PET/CT in the management of thyroid cancer.
Iagaru A; Kalinyak JE; McDougall IR
Clin Nucl Med; 2007 Sep; 32(9):690-5. PubMed ID: 17710020
[TBL] [Abstract][Full Text] [Related]
15. F18-FDG-PET/CT thyroid incidentalomas and their benign or malignant nature: a critical and debated issue.
Bertagna F; Giubbini R
Ann Nucl Med; 2011 Feb; 25(2):151-2. PubMed ID: 21104345
[No Abstract] [Full Text] [Related]
16. Characteristics of primary papillary thyroid carcinoma with false-negative findings on initial (18)F-FDG PET/CT.
Choi JW; Yoon YH; Yoon YH; Kim SM; Koo BS
Ann Surg Oncol; 2011 May; 18(5):1306-11. PubMed ID: 21140231
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte Colony-Stimulating Factor Administration at 1 Hour Before 18F-FDG PET Does Not Increase Bone Marrow FDG Accumulation.
Kawabata K; Hosono M; Tanaka H; Hyuga M; Kanagaki M
Clin Nucl Med; 2021 Sep; 46(9):770-771. PubMed ID: 33883491
[TBL] [Abstract][Full Text] [Related]
18. Two cases of thyroid carcinoma producing granulocyte colony-stimulating factor.
Kitanishi T; Suzuki M; Fukui J; Taniguchi K; Kitano H; Yazawa Y; Kitajima K
J Otolaryngol; 2000 Jun; 29(3):174-8. PubMed ID: 10883833
[No Abstract] [Full Text] [Related]
19. [Clinical application of (18)F-FDG PET/CT to staging and treatment effectiveness monitoring of nasopharyngeal carcinoma].
Wang GH; Lau EW; Shakher R; Binns DS; Hogg A; Drummond E; Hicks RJ
Ai Zheng; 2007 Jun; 26(6):638-42. PubMed ID: 17562272
[TBL] [Abstract][Full Text] [Related]
20. Positron Emission Tomography/Computed Tomography Findings of Granulocyte Colony-stimulating Factor-producing Lung Cancer.
Okano Y; Morishita A; Naruse K; Takeuchi E
Intern Med; 2022 Jul; 61(14):2241-2242. PubMed ID: 34980799
[No Abstract] [Full Text] [Related]
[Next] [New Search]
